Vital Signs Monitoring Devices Market is expected to reach US$ 11.12 Billion by 2033, Market Size, Share, Industry, Forecast and Outlook 2025-2033.

The global vital signs monitoring devices market reached US$ 5.35 Billion in 2023, with a rise of US$ 5.73 Billion in 2024 and is expected to reach US$ 11.12 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
The global vital signs monitoring devices market is expanding due to demographic, technological, and healthcare trends. Chronic diseases like hypertension, diabetes, and cardiovascular disorders are increasing, leading to a demand for accurate monitoring solutions. Advances in medical technology, such as wireless connectivity, wearable sensors, and artificial intelligence, have improved the capabilities and integration of vital signs monitoring devices. The growing acceptance of home healthcare, especially among the elderly and patients with long-term conditions, is reshaping how vital health data is captured and managed.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/vital-signs-monitoring-devices-market?pratik

United States: Key Industry Developments
✅ November 2025: OMRON Healthcare received De Novo authorization from the U.S. Food and Drug Administration to market new home blood pressure monitors that feature an AI-powered atrial fibrillation detection algorithm, which automatically analyzes the pressure pulse wave during measurement.

✅ August 2025: The U.S. vital signs monitoring devices market saw increased growth opportunities due to expanded Medicare reimbursement policies for home monitoring of chronic diseases, encouraging the use of at-home vital signs monitoring kits, particularly for post-operative care.

✅ December 2025: Contec released the
CMS8500,a next-generation multi-parameter patient monitor with a 14-inch high-definition touchscreen for comprehensive monitoring of adult, pediatric, and neonatal patients in various clinical settings.

✅ April 2025: Masimo Corporation, a leader in noninvasive monitoring, secured USD 200 million in a funding round to expand its product portfolio, accelerate research and development, and enhance its global presence in the vital signs monitoring market.

Japan: Key Industry Developments
✅ 2025 : The Japanese government has been heavily investing billions in research grants for the development of wearable ECG monitors, smart blood pressure monitors, and AI-powered health tracking devices, driving the need for advanced continuous health monitoring solutions.

✅ 2025 : In Japan, the implementation of 5G-enabled smart healthcare infrastructure services improved real-time remote patient monitoring, allowing patient vital signs and other health units to be accurately and continuously tracked in home-based and elderly living arrangements.

Recent M&A :-
→ October 2025: SB TEMPUS, a joint venture between SoftBank Group Corp. and Tempus AI, Inc., acquired all shares of Konica Minolta REALM. The acquisition is based on an earlier agreement in January 2025 and is aimed at expanding SB TEMPUS's genomics testing business. This allows SB TEMPUS to launch a genomics testing business leveraging GenMine Labs' knowledge and networks in genetic testing and cancer genome profiling, contributing to cancer diagnostics and precision medicine in Japan.

→ September 2025: Tracxn, a company that tracks acquisitions, reported that Masimo made its most recent acquisition, Nura, in September 2025. While Nura is a consumer electronics brand, the acquisition occurred within the vital signs monitoring market timeframe requested.

→ November 2024 (Not in Q4 2025): While not in the specified period, it's notable that in November 2024, Acutus Medical announced it would cut a significant portion of its staff to meet its obligations to Medtronic related to an earlier deal for its left-heart access devices. This reflects the ongoing restructuring and market dynamics affecting companies within the broader medical device sector.

Report Objectives
→ The global vital signs monitoring devices market report delivers a detailed analysis with 62 key tables, more than 57 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=vital-signs-monitoring-devices-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

Segmentation by End User
→ Hospitals & Clinics: This segment includes public and private hospitals, specialty clinics, and outpatient facilities that use vital signs monitoring devices for continuous patient monitoring, early-warning systems, and ICU/critical care management. It is the dominant end-user segment with an estimated market share of 60% in 2025, driven by high patient volumes and the adoption of remote monitoring solutions.

→ Home Healthcare: This segment covers devices used by patients at home, including wearable monitors and portable devices for tracking heart rate, blood pressure, oxygen saturation, and temperature. It accounts for roughly 25% of the market, with growth fueled by increasing demand for telehealth, chronic disease management, and aging population care.

→ Ambulatory Care & Other Settings: This segment includes outpatient centers, emergency transport, and telemedicine applications. It holds an estimated 15% market share, growing due to adoption of mobile monitoring devices and integration with digital health platforms.

Segmentation by Product Type
→ Multiparameter Monitors: Devices that simultaneously track multiple vital signs such as heart rate, SpO2, blood pressure, and temperature. This product type is the largest, with a market share of 45%, due to its extensive use in hospitals, ICUs, and surgical centers.

→ Single-Parameter Monitors: Devices measuring a single vital sign (e.g., pulse oximeters, thermometers, or blood pressure monitors). They constitute approximately 30% of the market, largely driven by home healthcare and outpatient applications.

→ Wearable Devices: Includes smartwatches, patches, and other wearable sensors for continuous monitoring. Estimated market share is 20%, growing rapidly due to technological innovations, consumer awareness, and integration with telemedicine platforms.

→ Others: This includes handheld, portable, and niche devices like fetal monitors or neonatal-specific vital signs monitors. These hold a smaller share of 5%, as they serve specialized use cases but are gaining traction with technological advancements.

Regional insights:-
→ North America dominates the vital signs monitoring devices market with the largest share, approximately 40% as of recent estimates. This leadership stems from advanced healthcare infrastructure, high adoption of innovative technologies, and a high prevalence of chronic diseases, particularly in the U.S.​

→ Asia-Pacific represents the fastest-growing region, driven by rapid urbanization, rising healthcare investments, increasing elderly populations, and demand for remote monitoring solutions in countries like China and India. It is projected to achieve high CAGRs, such as 9.4% through 2030, fueled by expanding telemedicine and wearable adoption.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/vital-signs-monitoring-devices-market?pratik

Competitive Landscape
→ The major players in the vital signs monitoring devices market include Koninklijke Philips N.V., Medtronic Nihon Kohden Corporation, GE Healthcare, Masimo Corporation, Omron Healthcare, Contec Medical Systems Co., Ltd., A&D Company Ltd., Nonin Medical Inc., and SunTech Medical, Inc., among others.

Key Developments
→ In February 2025, Smedo, founded by serial entrepreneur Thomas Grellner, offers an efficient, affordable, and automated method for monitoring life functions like heartbeat, heart rate variability, heart sound, respiration rate, and blood pressure. This innovative technology is expected to lead to a more efficient healthcare environment, as traditional methods are time-consuming and costly, causing significant damage to nursing staff and hospitals.

→ In January 2024, Blue Spark Technologies launched a unique multi-sensor remote patient monitoring platform, VitalTraq, which includes a contactless vital sign measurement sensor, Remote Photoplethysmography (rPPG). This allows patients, clinicians, and researchers to collect digital measurements of vital signs like Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate in a single contactless patient experience.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.